Adriëtte Oostvogels

2 55 pBMI, lipids and BP during pregnancy 19. Gratacos E. Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol Reprod Biol . 2000;92(1):63-66. 20. Savvidou M.D., Hingorani A.D., Tsikas D., Frolich J.C., Vallance P., Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet . 2003;361(9368):1511-1517. 21. van Eijsden M., Vrijkotte T.G., Gemke R.J., van der Wal M.F. Cohort profile: the Amsterdam Born Children and their Development (ABCD) study. Int J Epidemiol . 2011;40(5):1176-1186. 22. WHO. Global Database on Body Mass Index 2014 [cited 2014 March 10th]. Available from: www. who.int/bmi. 23. Buuren van S.G.-O., K. MICE: Multivariate Imputation by Chained Equations in R. 2010;10:1-68. 24. Carpenter M.W. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care . 2007;30 Suppl 2:S246-S250. 25. Stewart A.W., Jackson R.T., Ford M.A., Beaglehole R. Underestimation of relative weight by use of self-reported height and weight. Am.J.Epidemiol. 1987;125(1):122-126. 26. Langsted A., Freiberg J.J., Nordestgaard B.G. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation . 2008;118(20):2047-2056. 27. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA . 2007;298(3):309-316. 28. Ramsay J.E., Ferrell W.R., Crawford L., Wallace A.M., Greer I.A., Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab . 2002;87(9):4231-4237. 29. Bizbiz L., Alperovitch A., Robert L. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study. Atherosclerosis . 1997;131(1):73-78. 30. Faury G., Ristori M.T., Verdetti J., Jacob M.P., Robert L. Effect of elastin peptides on vascular tone. J Vasc Res . 1995;32(2):112-119. 31. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation . 1979;60(3):473-485. 32. Nordestgaard B.G., Wootton R., Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol . 1995;15(4):534-542. 33. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest . 1992;89(1):10-18. 34. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA . 1999;282(22):2131-2135. 35. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord . 1998;22(12):1145-1158. 36. de Jonge L.L., Steegers E.A., Ernst G.D., Lindemans J., Russcher H., Hofman A., et al. C-reactive protein levels, blood pressure and the risks of gestational hypertensive complications: the Generation R Study. J Hypertens . 2011;29(12):2413-2421. 37. Wolf M., Kettyle E., Sandler L., Ecker J.L., Roberts J., Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol . 2001;98(5 Pt 1):757-762.